Skip to main content
Premium Trial:

Request an Annual Quote

Beckman, Immune Tolerance Network Open Cell-based Assay Core Lab

NEW YORK, Sept. 27 (GenomeWeb News) - Beckman Coulter and the Immune Tolerance Network have opened a core laboratory to develop, standardize, and automate cell-based tests for clinical trials at Beckman's facility in Miami, the company said today.

 

Researchers from ITN, Beckman, and investigators from the USand Europeplan to develop and validate new cellular assays of T-cell responses for monitoring immune tolerance in clinical trials. "We believe that Beckman Coulter has a special expertise in these areas and look forward to working with the company in developing a number of these assays," said Hugh Auchincloss, chief operating officer of ITN, in a statement.

 

The Immune Tolerance Network, based at the Universityof California, San Francisco, is an international research collaboration with a dozen core facilities.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.